Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma

There is currently no standard salvage chemotherapy regimen in relapsed and refractory lymphoma. Gemcitabine is a novel nucleoside analogue, which acts synergistically with cisplatin both in vitro and in clinical studies. We evaluated the combination of gemcitabine, cisplatin and methylprednisolone...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, M, Waters, J, Cunningham, D, Chau, I, Horwich, A, Hill, M, Norman, A R, Wotherspoon, A, Catovsky, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361993/
https://www.ncbi.nlm.nih.gov/pubmed/15812553
http://dx.doi.org/10.1038/sj.bjc.6602514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361993/
https://www.ncbi.nlm.nih.gov/pubmed/15812553
http://dx.doi.org/10.1038/sj.bjc.6602514

Ejemplares similares